BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 10644418)

  • 1. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy.
    Hesse L; Nebeling B; Schroeder B; Heller G; Kroll P
    Exp Eye Res; 2000 Jan; 70(1):31-9. PubMed ID: 10644418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An experimental study on dissolving and detaching vitreoretinal interface with enzymes].
    Wang LF; Ma JX; Liu JZ; Cai SZ; Lu LC; Wang ZD
    Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):459-64. PubMed ID: 15454060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit.
    Hikichi T; Kado M; Yoshida A
    Retina; 2000; 20(2):195-8. PubMed ID: 10783954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic vitreolysis with recombinant microplasminogen and tissue plasminogen activator.
    Chen W; Huang X; Ma XW; Mo W; Wang WJ; Song HY
    Eye (Lond); 2008 Feb; 22(2):300-7. PubMed ID: 17704761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Posterior Vitreous Detachment in Pediatric Vitrectomy by Preoperative Intravitreal Injection of Tissue Plasminogen Activator.
    Chuang CC; Chen SN
    J Pediatr Ophthalmol Strabismus; 2016; 53(2):113-8. PubMed ID: 27018884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator as a biochemical adjuvant in vitrectomy for proliferative diabetic vitreoretinopathy.
    Hesse L; Chofflet J; Kroll P
    Ger J Ophthalmol; 1995 Nov; 4(6):323-7. PubMed ID: 8751095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous.
    Takano A; Hirata A; Inomata Y; Kawaji T; Nakagawa K; Nagata S; Tanihara H
    Am J Ophthalmol; 2005 Oct; 140(4):654-60. PubMed ID: 16140249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits.
    Ameri H; Kim JG; Ratanapakorn T; Chader GJ; Humayun MS
    Retina; 2008 Feb; 28(2):350-5. PubMed ID: 18301042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmin treatment accelerates vascular endothelial growth factor clearance from rabbit eyes.
    Wu WC; Chen CC; Liu CH; Wang NK; Chen KJ; Chen TL; Hwang YS; Li LM; Lai CC
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6162-7. PubMed ID: 21245395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of tissue plasminogen activator on premacular hemorrhage.
    Chung J; Kim MH; Chung SM; Chang KY
    Ophthalmic Surg Lasers; 2001; 32(1):7-12. PubMed ID: 11195747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enzymatically induced posterior vitreous detachment in proliferative diabetic vitreoretinopathy].
    Hesse L; Kroll P
    Klin Monbl Augenheilkd; 1999 Feb; 214(2):84-9. PubMed ID: 10218200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema.
    Asami T; Terasaki H; Kachi S; Nakamura M; Yamamura K; Nabeshima T; Miyake Y
    Ophthalmology; 2004 Feb; 111(2):231-7. PubMed ID: 15019368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile of the intravitreal streptokinase-plasmin complex as an adjunct to vitrectomy in the rabbit.
    Hermel M; Mahgoub M; Youssef T; Azrak MI; Raza H; Alldredge C; Trese M; Williams GA; Hartzer M
    Graefes Arch Clin Exp Ophthalmol; 2006 Aug; 244(8):996-1002. PubMed ID: 16365737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes.
    Sakuma T; Tanaka M; Mizota A; Inoue J; Pakola S
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3295-9. PubMed ID: 16123432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGD peptide-assisted vitrectomy to facilitate induction of a posterior vitreous detachment: a new principle in pharmacological vitreolysis.
    Oliveira LB; Meyer CH; Kumar J; Tatebayashi M; Toth CA; Wong F; Epstein DL; McCuen BW
    Curr Eye Res; 2002 Dec; 25(6):333-40. PubMed ID: 12789539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Posterior vitreous detachment induced by intravitreal injection of the combination of chondroitinase ABC and matrix metalloproteinase-3].
    Meng ZJ; Zeng SQ
    Zhonghua Yan Ke Za Zhi; 2004 Sep; 40(9):625-31. PubMed ID: 15500769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of posterior vitreous detachment induced by intravitreal tissue plasminogen activator in macular edema with central retinal vein occlusion.
    Murakami T; Takagi H; Ohashi H; Kita M; Nishiwaki H; Miyamoto K; Watanabe D; Sakamoto A; Yamaike N; Yoshimura N
    Retina; 2007 Oct; 27(8):1031-7. PubMed ID: 18040240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas.
    Chen CY; Hooper C; Chiu D; Chamberlain M; Karia N; Heriot WJ
    Retina; 2007 Mar; 27(3):321-8. PubMed ID: 17460587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new technique for separation of posterior vitreous in vitreous surgery.
    Shinoda K; Inoue M; Katsura H; Ishida S
    Ophthalmic Surg Lasers; 1999; 30(7):588-90. PubMed ID: 10929988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment.
    Men G; Peyman GA; Genaidy M; Kuo PC; Ghahramani F; Blake DA; Bezerra Y; Naaman G; Figueiredo E
    Retina; 2004 Apr; 24(2):199-209. PubMed ID: 15097878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.